Apoptosis targeted therapies in acute myeloid leukemia: an update
- 1 December 2020
- journal article
- other
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 13 (12) , 1373-1386
Abstract
Management of acute myeloid leukemia (AML) continues to be a therapeutic challenge despite significant recent advancements. Dysregulation of several components of apoptotic pathways has been identi...Keywords
This publication has 90 references indexed in Scilit:
- Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: Its correlation with FLT3Neoplasma, 2014
- BH3 profiling – Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisionsCancer Letters, 2013
- TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeBlood, 2012
- Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemiaGenes & Development, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cellsEuropean Journal of Haematology, 2010
- Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemiaBlood, 2010
- FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD–specific STAT5 activationBlood, 2009
- Mdm2 and Mdm4 Loss Regulates Distinct p53 ActivitiesMolecular Cancer Research, 2008
- Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaCancer Cell, 2006